4-(2-(3,4-DICHLOROPHENYL)DIAZENYL)-N-(2-ETHYLPHENYL)-3-HYDROXY-2-NAPHTHALENECARBOXAMIDE
UNII NBM7B8ZDG2
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-(3,4-dichlorophenyl)diazenyl)-n-(2-ethylphenyl)-3-hydroxy-2-naphthalenecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NBM7B8ZDG2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 72088-86-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H19Cl2N3O2 VWWJVCHVKLUVNS-QVIHXGFCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-(3,4-dichlorophenyl)diazenyl)-n-(2-ethylphenyl)-3-hydroxy-2-naphthalenecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.